Novartis says Alcon glaucoma treatment approved in EU

ZURICH (Reuters) - Swiss pharmaceutical group Novartis said the European Commission has approved its eyecare unit Alcon's Simbrinza treatment for glaucoma, a chronic, sight-threatening eye disease.

via Reuters: Health News Read More Here..